Cargando…
Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
OBJECTIVES: T3 disease comprises heterogeneous morphologic characteristics, a variation only further complicated when in the context of N2-confirmed involvement. This study aims to examine whether or not specific features of T3 N2 non–small cell lung cancer are associated with improved 5-year overal...
Autores principales: | Wang, Jennifer C., Ding, Li, David, Elizabeth A., Atay, Scott M., Wightman, Sean C., McFadden, P. Michael, Harano, Takashi, Kim, Anthony W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390621/ https://www.ncbi.nlm.nih.gov/pubmed/36004267 http://dx.doi.org/10.1016/j.xjon.2022.02.001 |
Ejemplares similares
-
Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
por: Peng, Terrance, et al.
Publicado: (2022) -
Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022) -
Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy
por: Lieu, Dustin K., et al.
Publicado: (2021)